Clostridium difficile and inflammatory bowel disease: Role in pathogenesis and implications in treatment
Clostridium difficile and inflammatory bowel disease: Role in pathogenesis and implications in treatment作者机构:Infectious Disease UnitHa’emek Medical CenterAfula 18101Israel Bruce Rappaport Faculty of MedicineTechnion-Israel Institute of TechnologyHaifa 31096Israel Department of Internal Medicine CHa’emek Medical CenterAfula 18101Israel
出 版 物:《World Journal of Gastroenterology》 (世界胃肠病学杂志(英文版))
年 卷 期:2013年第19卷第43期
页 面:7577-7585页
核心收录:
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
主 题:Clostridium difficile Diarrhea Inflammatory bowel disease Pathogenesis Treatment
摘 要:Clostridium difficile(***)is the leading cause of antibiotic associated colitis and nosocomial *** with inflammatory bowel disease(IBD)are at increased risk of developing *** infection(CDI),have worse outcomes of CDI-including higher rates of colectomy and death,and experience higher rates of ***,it is still not clear whether *** is a cause of IBD or a consequence of the inflammatory state in the intestinal *** burden of CDI has increased dramatically over the past decade,with severe outbreaks described in many countries,which have been attributed to a new and more virulent strain.A parallel rise in the incidence of CDI has been noted in patients with *** patients with CDI tend be younger,have less prior antibiotic exposure,and most cases of CDI in these patients represent outpatient acquired *** clinical presentation of CDI in these patients can be unique-including diversion colitis,enteritis and pouchitis,and typical findings on colonoscopy are often *** to the high prevalence of CDI in patients hospitalized with an IBD exacerbation,and the prognostic implications of CDI in these patients,it is recommended to test all IBD patients hospitalized with a disease flare for *** includes general measures such as supportive care and infection control *** therapy with either oral metronidazole,vancomycin,or the novel antibiotic-fidaxomicin,should be initiated as soon as *** macrobiota transplantation constitutes another optional treatment for severe/recurrent *** aim of this paper is to review recent data on CDI in IBD:role in pathogenesis,diagnostic methods,optional treatments,and outcomes of these patients.